BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 17164361)

  • 41. Blood levels of long-chain polyunsaturated fatty acids, aspirin, and the risk of colorectal cancer.
    Hall MN; Campos H; Li H; Sesso HD; Stampfer MJ; Willett WC; Ma J
    Cancer Epidemiol Biomarkers Prev; 2007 Feb; 16(2):314-21. PubMed ID: 17301265
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Associations of recreational physical activity and leisure time spent sitting with colorectal cancer survival.
    Campbell PT; Patel AV; Newton CC; Jacobs EJ; Gapstur SM
    J Clin Oncol; 2013 Mar; 31(7):876-85. PubMed ID: 23341510
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Low-dose aspirin and incidence of colorectal tumors in a randomized trial.
    Gann PH; Manson JE; Glynn RJ; Buring JE; Hennekens CH
    J Natl Cancer Inst; 1993 Aug; 85(15):1220-4. PubMed ID: 8331682
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The risk of colorectal cancer in patients with type 2 diabetes: associations with treatment stage and obesity.
    Peeters PJ; Bazelier MT; Leufkens HG; de Vries F; De Bruin ML
    Diabetes Care; 2015 Mar; 38(3):495-502. PubMed ID: 25552419
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Aspirin use and colorectal cancer: post-trial follow-up data from the Physicians' Health Study.
    Stürmer T; Glynn RJ; Lee IM; Manson JE; Buring JE; Hennekens CH
    Ann Intern Med; 1998 May; 128(9):713-20. PubMed ID: 9556464
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prospective study of adult onset diabetes mellitus (type 2) and risk of colorectal cancer in women.
    Hu FB; Manson JE; Liu S; Hunter D; Colditz GA; Michels KB; Speizer FE; Giovannucci E
    J Natl Cancer Inst; 1999 Mar; 91(6):542-7. PubMed ID: 10088625
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [An epidemiological approach to the metabolic syndrome].
    Suka M; Yoshida K
    Nihon Koshu Eisei Zasshi; 2004 Aug; 51(8):623-30. PubMed ID: 15481549
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The impact of diabetes and other metabolic disorders on prostate cancer prognosis.
    Polesel J; Gini A; Dal Maso L; Stocco C; Birri S; Taborelli M; Serraino D; Zucchetto A
    J Diabetes Complications; 2016; 30(4):591-6. PubMed ID: 26936307
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Role of obesity in colorectal carcinogenesis].
    Hagymási K; Tulassay Z
    Orv Hetil; 2007 Dec; 148(51):2411-6. PubMed ID: 18055394
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Adult height and incidence of cancer in male physicians (United States).
    Hebert PR; Ajani U; Cook NR; Lee IM; Chan KS; Hennekens CH
    Cancer Causes Control; 1997 Jul; 8(4):591-7. PubMed ID: 9242474
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Risk of neoplastic and other diseases among people with heterozygosity for hereditary hemochromatosis.
    Nelson RL; Davis FG; Persky V; Becker E
    Cancer; 1995 Sep; 76(5):875-9. PubMed ID: 8625192
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Association of metabolic syndrome and colorectal cancer].
    Li L; Huang HL; Zhang XY; Zhang XY; Lv ZH
    Zhonghua Wei Chang Wai Ke Za Zhi; 2011 Dec; 14(12):948-51. PubMed ID: 22205455
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Metabolic syndrome, obesity, and the risk of cancer development.
    Bitzur R; Brenner R; Maor E; Antebi M; Ziv-Baran T; Segev S; Sidi Y; Kivity S
    Eur J Intern Med; 2016 Oct; 34():89-93. PubMed ID: 27545645
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Diabetes mellitus and the occurrence of colorectal cancer: an updated meta-analysis of cohort studies.
    Wu L; Yu C; Jiang H; Tang J; Huang HL; Gao J; Zhang X
    Diabetes Technol Ther; 2013 May; 15(5):419-27. PubMed ID: 23540566
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Colorectal cancer: another complication of diabetes mellitus?
    Will JC; Galuska DA; Vinicor F; Calle EE
    Am J Epidemiol; 1998 May; 147(9):816-25. PubMed ID: 9583711
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Association Between Colorectal Cancer and Atherosclerotic Diseases: A Study Using a National Inpatient Database in Japan.
    Yamaji Y; Yasunaga H; Hirata Y; Yamada A; Yoshida S; Horiguchi H; Fushimi K; Koike K
    Dig Dis Sci; 2016 Jun; 61(6):1677-85. PubMed ID: 26831490
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Diabetes and risk of incident colorectal cancer in a prospective cohort of women.
    Flood A; Strayer L; Schairer C; Schatzkin A
    Cancer Causes Control; 2010 Aug; 21(8):1277-84. PubMed ID: 20383575
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Breast cancer and diabetes mellitus: Complex interactions].
    Bernard L; Reix N; Benabu JC; Gabriele V; Mathelin C
    Gynecol Obstet Fertil; 2016 Dec; 44(12):701-711. PubMed ID: 27836525
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prospective cohort study of type 2 diabetes and the risk of Parkinson's disease.
    Driver JA; Smith A; Buring JE; Gaziano JM; Kurth T; Logroscino G
    Diabetes Care; 2008 Oct; 31(10):2003-5. PubMed ID: 18599528
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Self reported non-insulin dependent diabetes, family history, and risk of prevalent colorectal cancer: population based, cross sectional study.
    Sandhu MS; Luben R; Khaw KT
    J Epidemiol Community Health; 2001 Nov; 55(11):804-5. PubMed ID: 11604436
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.